Mistake 4: inadequate hydration GLP-1 receptor agonists can blunt thirst signals while simultaneously causing fluid loss through GI effects
TOPICS: Wegovy Price Drop Changes EverythingWhat This Podcast CoversNew Savings Programs ExplainedWhy This Is Bigger Than PriceThe Broken Healthcare SystemRise of Telehealth & CompoundingThe New Parallel System of CareGray Market vs Medical AccessSafety vs Strength DebateRisks of Unregulated MedicationsWhy Long-Term Support MattersGray Market Supply ConcernsPharma Pressure & RegulationWhat Happens If Access ChangesTrust Issues with the System The Core Question: Safety or PowerAre OTC GLP-1s Coming?New Oral Drugs & NexboundWhy Pills Could Change EverythingAccess vs CareGLP-1s as Longevity DrugsEli Lillys Big Bet on the FutureThe Next 510 Years Retatrutide Is Too Good And Thats The Problem Access to compounded and research-grade GLP-1s may be tightening, as comments from Robert F
Less muscle means a lower resting metabolic rate, so the same slice of cake lands differently
Food intake, particularly ingestion of carbohydrate-rich food, increases GLP-1 secretion, which promotes post-prandial insulin secretion, -cell proliferation, and glucose homeostasis, contributing to reducing glucose levels and aiding weight loss
Key findings from SURMOUNT-5 at 72 weeks: Tirzepatide produced a mean body weight reduction of 20.2% compared to 13.7% with semaglutide